A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/8490909

Cancer 1993 Jun 1 71 11 3601-4

Download in:

View as

Triples

General Info

PMID
8490909